Conference Information

About Conference

With the success of its previous series, Organizing Committee of Advanced Heart 2020 is glad to invite all the cardiologists, research scholars, students and other academicians to the upcoming series Advanced Heart 2021. The conference is designed with a theme of ‘Addressing cardiac management goals through health action’

This two-day event will cover Keynote sessions of leading experts, plenary talks and poster presentations of researchers and other academicians, workshop sessions, exhibition and B2B meetings conducted by leading companies leaving behind a memorable experience. Advanced Heart 2021 is one of the Cardiology Meetings which will be visited by all the prestigious cardiologists, cardiology educators, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop.

Advanced Heart 2021 includes 19 tracks designed to offer overarching sessions that addresses current issues in the field of Cardiology. Pulsus Group organizes 300+conferences, workshops and symposiums on Clinical, Medicine, Science & Technology.

This conference will provide an extensive update on all clinical, surgical, and interventional, topics in cardiology. Experts with national and international reputations in various fields will address the latest guidelines, therapeutic approaches, recent trends, etc., in cardiovascular medicine. Additionally, attendees will learn about recent trials being practiced that are likely to influence future practices. The areas of cardiology that will be covered are: Heart Diseases, Cardiovascular Diseases, Heart Failure, Diabetes, Imaging, Heart health in women, Pediatric, Prevention and recent research trends in Cardiology.

Conference highlights include:

100+ participants (Both Industry and academia)
11+Keynote speakers
30+ Plenary speakers
10+ Exhibitors
Innovative educational sessions
B2B meetings
Hands-on Workshop

Why to attend??

Unlike all other conferences, Advanced Heart 2021 is meant to build a professional network among the people belonging to same field. It also an excellent chance for the researchers to showcase their work and to gain support in moving further with their fascinating ideas by collaborating with the universities or leading companies. Medical graduates are offered with an excellent opportunity to decide their future study interest by discussing with the professionals. The workshop sessions are meant to learn new treatment methods along with the knowledge of handling them in future. The Delegates are benefited by being a part in all the conference sessions and to take part in the workshops, B2B meetings and all other interactive sessions. Apart from the knowledge through talks, posters and other sessions, the exhibitors provide you an additional experience by displaying their recent trends that keeps you updated even with industrial advancements.

Target Audience

Cardiologists
Academicians
Research Scholars
Industrial Professionals
Academic Scientists
Pharmacologists
Business Delegates
Medical Students
Laboratory Technicians
Sonographers
Postdoctoral fellows and trainees

Scientific Session

+-6+These 19 tracks of Advanced Heart 2020 are designed in such a way that they bring out the innovations, promote & improve results in this dynamic field offering a complete exchange of knowledge between its participants.

Track 1: Fundamentals of Cardiology

Cardiology is a medical domain and an outlet of internal medicine associated with heart and the circulatory system. It deals with the diagnostic and therapeutic procedures of heart conditions. Individuals qualified in Cardiology are called Cardiologists. Pediatricians specialized in Cardiology are Paediatric Cardiologists. Physicians specialized in surgery are called Cardiac Surgeons. Their roles differ depending on the type of heart conditions.

Related Conferences: Meeting of the Asian Society for Cardiovascular and Thoracic Surgery, February 7-10, 2020, Chiang Ming, Thailand; International Stroke Conference, February 19-21, 2020, Los Angeles, California; Cardiovascular Research Technologies, February 22-25, 2020, National Harbor, Maryland; The Houston Aortic Symposium: Frontiers in Cardiovascular Diseases, March 05-07, 2020, Houston, Texas; Cardiology Update at Puerto Vallarta: A Focus on Prevention, January 06-10, 2020, Puerto Vallarta, Mexico; Cardiac CT Practicum: The Total Experience, January 13-17, 2020, Baltimore, United States; Advances in Nuclear Cardiology, Cardiac CT and Cardiac MRI: 35th Annual Case Review with the Experts, January 17-19, 2020, Los Angeles, California

Cardiology Conferences | Cardiology Summit | Heart Congress

Track 2: Heart Disorders

When the heart fails to function normally, it leads to various heart disorders like hypertension, cardiac arrhythmia, coronary artery disease, cardiac arrest, congenital heart defects, etc. Many disorders involve the heart while some are found in the vascular system as well.

Related Conferences: World Congress on Cardiology and Heart Diseases, April 27-28, 2020, Seoul, South Korea; Congress of the Association of Thoracic and Cardiovascular Surgeons of Asia, November 05-08, 2020, Phuket, Thailand; 30th European Days of The French Society of Cardiology 2020, January 15-18, 2020, Paris, France; Venous Association of India 13th Annual Conference 2020, January 16-19, 2020, Mumbai, India; Cardiovascular Conference at Snowmass, January 18-22, 2020, Snowmass Village, Colorado; Mayo Clinic Hawaii Echo with Multimodality Imaging, January 20-24, 2020, Kapalua, United States

Cardiac Diseases Conference | Heart Conferences | Heart Summit

Track 3: Cardiovascular Diseases

Cardiovascular diseases are conditions which involves narrowed or blocked blood vessels which can lead to many forms of heart diseases. The symptoms of these diseases depend upon the type of heart disease and it may differ for men and women. Some cardiovascular diseases are inherited. Genes can pass on the risk of cardiovascular diseases in families. The other types of cardiovascular diseases are caused due to environmental factors. These types of diseases can be prevented by making changes in an individual's lifestyle.

Related Conferences: International Society for Heart and Lung Transplantation Annual Meeting, April 22-25, 2020, Montreal, Canada; 25th Annual International AF Symposium 2020, January 23-25, 2020, Maryland, United States; Echo Hawaii, January 20-24, 2020, Kohala Coast, United States; Advanced Heart Failure Shared Care Symposium, January 24, 2020, Minneapolis, United States; Arrhythmias and the Heart: A Cardiovascular Update; January 27-31, 2020, Kohala Coast, United States; 14th Annual Meeting of the Congenital Cardiac Anesthesia Society, February 27, 2020, Paradise Island, Bahamas; 12th International Conference on Acute Cardiac Care, June 28-30, 2020, Tel Aviv, Israel

Cardiovascular Conferences | Heart Failure Conference | Cardiology Congress

Track 4: Pediatric Cardiology

Pediatric Cardiology is a branch of medicine dealing with the diagnostic and therapeutic approaches to heart diseases in infants and neonates. Pediatric cardiologists broadly treat congenital heart disease, arrhythmias and disturbances of circulatory function in children.

Related Conferences: Global Heart Congress, March 18-19, 2020, Berlin, Germany; 9th Annual Structural Heart Intervention and Imaging 2020, February 05-07, 2020, San Diego, United States; 22nd Tremblant Interventional Cardiology Meeting 2020, February 05-08, 2020, Mont-Tremblant, Canada; ICCA STROKE 2020, March 20-21, 2020, Frankfurt, Germany; 6th International Meeting On Cardiac Problems In Pregnancy 2020, April 02-05, 2020, Porto, Portugal; European Heart Rhythm Association Congress, March 29-31, 2020, Vienna, Austria; 30th Annual Congress of the Association of Thoracic and Cardiovascular Surgeons of Asia, November 05-08, 2020, Phuket, Thailand

Pediatric Cardiology Conference | Heart Congress | Preventive Cardiology Conferences

Track 5: Interventional Cardiology

Interventional Cardiology, a sub field of Cardiology includes catheter-based, invasive therapeutic approach for heart diseases. Interventional Cardiologists are specialized in both diagnosis and treatment of various heart and cardiovascular diseases with the use of catheters. Different types of Interventional procedures include: Cardiac Catheterization, Angioplasty, Stenting, etc. The main advantages of interventional cardiology procedures are avoids scares, less pain, etc.

Interventional Cardiology Conferences | Cardiology Summit | Heart Congress

Track 6: Hypertension

Hypertension is a simple medical term where there is a continuous increase in blood pressure as the blood exerts high pressure onto the walls. The symptoms of high blood pressure might be a headache, fatigue, chest pain, etc. In simple words, Hypertension is known as High Blood Pressure. It can sometimes lead to serious complications which increases the risk of heart failure.

Hypertension Conferences | Global Heart Summit | Cardiovascular Conference

Track 7: Cardiovascular Imaging

One of the sub-specialities of the diagnostic radiography is the Cardiaovascular Imaging. The major duty of the cardiovascular radiologist is to perform tests and to diagnose the diseases such as the leaking heart valves, deformities in shape and size of heart, etc. Giving the increasing use of these non-invasive modalities to diagnose and manage cardiovascular diseases, the radiologists must be familiar with those techniques.

Cardiac Imaging Conferences | Heart Congress | Heart Surgery Conference

Track 8: Cardio-oncology

Cardio-oncology refers to the branch of cardiology dealing prevention or treatment of heart complications due to cancer treatment. Cardio-oncology specialists are oncologists and cardiologists.

Oncology Conferences | Cardiology Summit | Heart Disease Conference

Track 9: Cardiac Surgery

The surgical operations performed on the heart is called cardiac surgery. It is also known as cardiovascular surgery. A surgery is recommended only under life-threatening conditions. The main purpose of cardiac surgery is to increase the lifespan of the patient by improving the function of heart. These operations are performed by cardiac or cardiothoracic surgeons.

Cardiac Surgery Conference | Preventive Cardiology Congress | Cardiology Conferences

Track 10: Cardiac Transplantation

Cardiac Transplantation has been a common therapeutic solution for individuals with higher risk or end-stage heart failure. It is a process of replacing an ailing heart with a healthy heart. A healthy heart is received from a donor.

Heart Surgery Conference | Cardiac Nursing Congress | Cardiovascular Medicine Conferences

Track 11: Management of Heart Failure

When the efficiency of the heart reduces thereby resulting in the decreased supply of blood and oxygen throughout the body, the condition is known as Heart Failure. The most common causes include Hypertension, Heart attack, coronary artery disease etc. The condition usually gets worse over time, however the treatment methods based on proper diagnosis can help us feel better and live longer.

Heart Failure Conference | Cardiac Surgery Congress | Preventive Cardiology Conferences

Track 12: Heart health in women

The rate of heart failure is comparatively lower in women than men. However, cardiovascular diseases continue to be the leading cause of female mortality in many places. Sex-specific data has shown a slight increase in the risk of heart diseases in women. This data therefore can provide a novel sense to heart health in women.

Cardiology Conferences | Heart Disease Summit | Interventional Cardiology Conference

Track 13: Case Reports in Cardiology

A case report is generally an evidence associated with several fields of cardiology that examines various issues. Case reports on cardiac disorders have a great significance and help in the development and advancement in therapeutic strategies. These reports also have a recognition of new diseases and treatment options.

Case Report Conferences | Cardiovascular Summit | Cardiac Surgery Conferences

Track 14: Clinical Trials

Clinical trials are research investigations where people test new treatments, tests or interventions to prevent, detect, treat or manage medical conditions. There are 2 main types of clinical trials:

Interventional
Observational

Clinical Trail Conferences | Cardiology Congress | Heart Failure Conference

Track 15: Diabetes and Heart

Diabetes or high blood glucose levels can damage the heart. It has become a growing concern in the modern generation increasing the risk of many heart diseases like heart failure, stroke, etc. One can lower the risk of heart diseases by simply changing the lifestyle.

Diabetes Conferences | Heart Surgery Congress | Interventional Cardiology Conference

Track 16: Cardiac Nursing

Unlike other nursing specialities, the professionals in cardiac nursing requires an understanding of normal cardiac anatomy and physiology. They take care of the critically ill patients and those who are in the recovering stage by performing stress tests, complete health assessments, caring for a patient after any cardiac procedures, or closely monitoring the patient’s heart rate. They also work as a part of a team under direction of a cardiologist.

Cardiac Nursing Conferences | Nursing Summit | Preventive Cardiology Conference

Track 17: Cardiac Pharmacology

Pharma Industry is a type of industry where the drugs are discovered, developed, produced and marketed. With the development of new technologies, the pharma industry has taken a great leap. Many cardiac contributions are being tested for its effectiveness by clinical trials.

Cardiac Pharma Conferences | Global Heart Congress | Pharma Conference

Track 18: Preventive Cardiology

Cardiovascular disease (CVD) is the major cause of death in Europe and rest of the world. A preventive approach to the CVD is feasible and justified because epidemiologic research has identified several modifiable predisposing lifestyles and personal attributes, that when corrected have been shown to reduce the likelihood of development of atherosclerotic cardiovascular diseases.

Preventive Cardiology Conferences | Heart Failure Summit | Cardiovascular Conference

Track 19: Recent Trends

Various research advances have donated to expand the results across all areas of Cardiology such as new developments in the treatment of cardiogenic shock, novel stent technology and many more. Simultaneously, it is observed that there is a swift upsurge in the populations of patients with heart disorders. Due to this, the expectations of patients for new advancements also develop. Therefore, future Cardiology world may show a novel approach.

Clinical Cardiology Conferences | Global Heart Summit | Interventional Cardiology Conference

Market Analysis

Congestive Heart Failure Treatment market:

Congestive heart failure develops when ventricles unable to pump enough volume of blood to the body. Increase in the prevalence of cardiovascular diseases across regions is the major factors expected to drive the revenue growth of congestive heart failure treatment globally. Lifestyle-related factors are expected to add to the growing disease incidence of CVDs. In addition, the growing number of obese patients is expected to bolster the congestive heart failure treatment market. The huge treatment demand for congestive heart failure is expected to boost the treatment market. However, the availability of the generic drugs and lack of end-stage pipeline drugs and therapies for congestive heart failure treatment is about to hinder the market.

Congenital Heart Disease market report evaluated the historical and current performance of the market, especially highlighting the key trends and growth opportunities. Congenital Heart Disease market report discussed the present scenario of market size with respect to volume and share. Congenital Heart Disease market report contains the growth pattern by the company, applications, types, and regions from 2019 -2023. Congenital Heart Disease market report also covers an in-depth analysis of the competitive landscape, future development trends, and key manufacturers of the industry.

The factors driving the global market growth of the congenital heart disease are rising prevalence of congenital heart disease & the rise in the adoption of minimally invasive procedures. Further, many Influenced market players, growing demand for catheterization & application of cardiac biomarkers in congenital heart disease treatment are also considered as a major factor for driving the growth of the global congenital heart disease market during the forecast period.

Market Highlights

Increasing disease prevalence and uptake of branded therapies will result in considerable growth of the CHF market over the 2017–26 forecast period, with sales, increasing from $2.9bn to $8.3bn.
Entresto has now overcome initial barriers in the form of reimbursement delays and physicians’ reluctance to shift from traditional treatment practices. Its sales have risen to over $1,028m in 2018, primarily driven by the class I recommendation in US and EU treatment guidelines.
Current treatment practices for CHF are dominated by generic therapies, placing pressure on the pipeline to demonstrate strong cost/efficacy profiles.
Despite the dominance of generics, there is significant commercial potential for novel therapies that demonstrate a benefit in patients with CHF with preserved ejection fraction, which accounts for 50% of the CHF population. This is a major unmet need as the heterogeneous nature of the disease renders it difficult to identify promising modes of action.
The high co-occurrence of diabetes with CHF means that the cardiovascular benefit of SGLT-2 inhibitors could facilitate significant uptake in this population. Studies investigating use in non-diabetic populations could further expand the target population.

Heart Failure Market to ascend to $11.8 Billion by 2025:

The heart failure market is set to rise from approx. $3.2 billion in 2015 to $11.8 billion by 2025, representing a compound annual growth rate of 13.7%, according to research and consulting firm Global Data.

Understanding the changing cardiovascular market:

Increasing demand for value
The rising uptake of innovative treatment technologies
Growing digital solutions adoption
Changing MedTech competitive landscape
Evolving provider and care delivery shifts

Cardiovascular Market Insights:

Improving medical imaging and robotic-assisted surgeries are major factors contributing to the growth of the cardiovascular catheters market.
Several segments within the cardiovascular drugs market are poised for steady growth, including the market for hypertension drugs.
An increasing number of M&A and strategic collaborations, as well as the increasing adoption of portable cardiac monitoring devices, are the key trends expected to positively impact the global cardiac monitoring market through 2021.

Global Interventional Cardiology Market to hit $24.96 Billion by 2027:

As stated in a Newmarket intelligence report by BIS Research, titled 'Global Interventional Cardiology Market - Analysis and Forecast, 2018-2027', the global interventional cardiology market was estimated at $14.69 billion in 2017, & is estimated to reach $24.96 billion by 2027. The global interventional cardiology market is expected to grow at a CAGR of 8.37% between the years 2018 & 2027, which is aided by the impressive growth of healthcare budgetary allocation and technological advancements in the medical device industry. Moreover, the rising prevalence of cardiac diseases & a growing geriatric population are the main factors leading to the growth of the market.

The medical devices industry has been witnessing an annual growth rate of approx. 4.5% from 2011. Increasing incidences of cardiac disorders and rise in the older population are significantly impacting the growth of the interventional cardiology market. As a result, several companies are making arduous efforts by innovating new products or redesigning existing devices to attain better process efficiency. Therefore, to sustain in the highly competitive market, interventional cardiology is gradually becoming an indispensable solution for the medical device industry. Moreover, with the advancement in technology, factors such as an increase in patient awareness for advanced medical devices and a rise in the occurrence of lifestyle disorders are expected to actively drive the growth of the interventional cardiology market during the period of 2018 to 2027.

Highlights:

Interventional cardiology procedure of primary angioplasty is regarded as the gold standard of care for acute myocardial infarction. The emergence of interventional cardiology devices has enabled the efficient treatment of ischemic heart disease, percutaneous coronary intervention (angioplasty), stent placement, coronary thrombectomy, valve disease (valvuloplasty, percutaneous valve repair or replacement), and congenital heart abnormalities. The main advantage of using advanced cardiac intervention devices is that the procedure eliminates the risk of scars and pain and reduces the post-operative recovery time.
The advanced interventional cardiology device market is expected to grow at a CAGR of 8.37% from 2018 to 2027. In this, the optical coherent tomography segmented is expected to grow at the highest CAGR of 9.30% from 2018 to 2027.
The global interventional cardiology market comprises substantial investments made by several conglomerate and small-medium enterprises. More than 400 products from about 100 companies are available in the market.
The ambulatory surgical centre segment is expected to witness a robust CAGR of 5.99% in the forecast period 2018-2027.

Global Interventional Cardiology Market: Focus on Devices, End Users, Regions- Analysis and Forecast from 2018 to 2027:

The global interventional cardiology market was estimated at $14.69 billion in 2017 and is anticipated to reach $24.96 billion by 2027. With the rise in the demand for advanced medical devices to treat cardiovascular diseases, increasing geriatric population with higher life expectancy, and new product launches by several conglomerate companies, the cardiac intervention market is expected to witness moderate growth. The emergence of advanced imaging modalities such as IntraVenous UltraSound (IVUS), Optical Coherent Tomography (OCT), and Fractional Flow Reserve (FFR) has led to the growth of the market.

The global interventional cardiology is segmented by the geographical regions into North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World (RoW). North America is the leading contributor to the global interventional cardiology market.

However, the Asia-Pacific is expected to grow at a CAGR of 7.12% in the forecast period 2018-2027. The global interventional cardiology market for advanced devices is majorly dominated by the U.S. and the European players.

The key players who have significant contributions to the global interventional cardiology market are Abiomed, Inc., ACIST Medical Systems, Inc., B. Braun Melsungen AG, Biotronik SE & Co. KG, Edwards Lifesciences Corporation, Life Vascular Devices Biotech S.L., Boston Scientific Corporation, C. R. Bard, Inc., Biosensors International Group, Ltd., Cook Medical LLC, Cordis Corporation, GE Healthcare, Biostense Webster, Inc., Medtronic Plc, Merit Medical Systems, Inc., Novacam Technologies Inc., Koninklijke Philips N.V., St. Jude Medical, Terumo Corporation, and W.L. Gore & Associates, Inc., among others.

Top drivers behind cardiovascular market growth by 2024

According to estimates published by Global Data’s Pharma Intelligence Center, total sales for cardiovascular disease drugs will grow steadily over the next 6 years, from almost $47 billion in 2018 to over $70 billion in 2024.

6^th International Heart Conference

Quick Links

Theme: Addressing Cardiac management goals through Health action

Conference Information

About Conference

Scientific Session

Market Analysis